MX2012007041A - Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri). - Google Patents

Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).

Info

Publication number
MX2012007041A
MX2012007041A MX2012007041A MX2012007041A MX2012007041A MX 2012007041 A MX2012007041 A MX 2012007041A MX 2012007041 A MX2012007041 A MX 2012007041A MX 2012007041 A MX2012007041 A MX 2012007041A MX 2012007041 A MX2012007041 A MX 2012007041A
Authority
MX
Mexico
Prior art keywords
mri
magnetic resonance
resonance imaging
contrast agents
manganese chelates
Prior art date
Application number
MX2012007041A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Meijer
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of MX2012007041A publication Critical patent/MX2012007041A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2012007041A 2009-12-18 2010-12-17 Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri). MX2012007041A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20093555A NO331773B1 (no) 2009-12-18 2009-12-18 Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
PCT/EP2010/070029 WO2011073371A1 (en) 2009-12-18 2010-12-17 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)

Publications (1)

Publication Number Publication Date
MX2012007041A true MX2012007041A (es) 2012-07-20

Family

ID=43770529

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007041A MX2012007041A (es) 2009-12-18 2010-12-17 Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).

Country Status (19)

Country Link
US (1) US9486544B2 (enExample)
EP (1) EP2512524B1 (enExample)
JP (1) JP5879268B2 (enExample)
KR (1) KR101860160B1 (enExample)
CN (1) CN102639152B (enExample)
AU (1) AU2010332760B2 (enExample)
BR (1) BR112012013761A2 (enExample)
CA (1) CA2781228A1 (enExample)
DK (1) DK2512524T3 (enExample)
ES (1) ES2606165T3 (enExample)
HR (1) HRP20161627T1 (enExample)
HU (1) HUE032152T2 (enExample)
LT (1) LT2512524T (enExample)
MX (1) MX2012007041A (enExample)
NO (1) NO331773B1 (enExample)
PL (1) PL2512524T3 (enExample)
PT (1) PT2512524T (enExample)
RU (1) RU2561718C2 (enExample)
WO (1) WO2011073371A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102231121B1 (ko) 2013-04-26 2021-03-23 게르브 조영제 제형 및 이와 관련된 제조 방법
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3380472A1 (en) 2015-11-26 2018-10-03 Debreceni Egyetem New 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca- 1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
US10968224B2 (en) 2015-11-26 2021-04-06 Debreceni Egyetem 2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
EP3380484A1 (en) 2015-11-26 2018-10-03 Debreceni Egyetem New 6-oxa-3,9, 15-triaza-bicyclo[9.3.1 ]pentadec a- 1 ( 14), 1 1 ( 15), 12-triene derivatives based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
GB201610738D0 (en) * 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
ES2814555T3 (es) 2016-11-28 2021-03-29 Bayer Pharma AG Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética
WO2018115314A1 (en) * 2016-12-21 2018-06-28 Ge Healthcare As Tetraazabicyclo-macrocycle based manganese chelate compounds suitable as mri imaging agents
EP3728168B1 (en) * 2017-12-20 2022-03-30 General Electric Company Anionic chelate compounds
IL321215A (en) 2018-11-23 2025-07-01 Bayer Ag Formulation of contrast media and process of preparation thereof
CN111233982B (zh) * 2018-11-28 2023-03-03 深圳先进技术研究院 一种小分子蛋白质及其应用
SI4025259T1 (sl) 2019-09-03 2025-03-31 Ge Healthcare As Izomeri manganovega kelata
CN114874214B (zh) * 2022-05-31 2023-03-21 南京航空航天大学 可偶联巯基的双功能大环螯合剂衍生物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5334371A (en) * 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
IE66694B1 (en) 1988-09-27 1996-01-24 Nycomed Salutar Inc Chelate compositions
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
MX9207164A (es) * 1991-12-10 1993-07-01 Dow Chemical Co Complejos de acido biciclopoliazamacrociclocarboxilico, sus conjugados, procedimientos para su preparacion y su uso como agentes de contraste.
WO1994026313A1 (en) 1993-05-06 1994-11-24 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
MX9207166A (es) * 1991-12-10 1993-07-01 Dow Chemical Co Acidos biciclopoliazamacrociclofosfonicos, sus complejos y conjugados, para uso como agentes de contraste, y procedimientos para su preparacion.
FR2836916B1 (fr) * 2002-03-05 2004-06-11 Guerbet Sa Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
US20080305049A1 (en) 2005-01-31 2008-12-11 Hadassa Degani Mri Contrast Agents for Diagnosis and Prognosis of Tumors

Also Published As

Publication number Publication date
US9486544B2 (en) 2016-11-08
AU2010332760A1 (en) 2012-06-07
RU2012124266A (ru) 2014-01-27
KR101860160B1 (ko) 2018-05-21
HRP20161627T1 (hr) 2017-01-13
PT2512524T (pt) 2016-12-15
BR112012013761A2 (pt) 2016-04-26
EP2512524A1 (en) 2012-10-24
CN102639152A (zh) 2012-08-15
NO20093555A1 (no) 2011-06-20
HUE032152T2 (en) 2017-09-28
WO2011073371A1 (en) 2011-06-23
RU2561718C2 (ru) 2015-09-10
NO331773B1 (no) 2012-03-26
CA2781228A1 (en) 2011-06-23
EP2512524B1 (en) 2016-10-05
PL2512524T3 (pl) 2017-08-31
JP2013514329A (ja) 2013-04-25
US20120244081A1 (en) 2012-09-27
DK2512524T3 (en) 2017-01-09
JP5879268B2 (ja) 2016-03-08
CN102639152B (zh) 2015-11-25
KR20120109505A (ko) 2012-10-08
LT2512524T (lt) 2016-12-12
AU2010332760B2 (en) 2016-01-07
ES2606165T3 (es) 2017-03-23

Similar Documents

Publication Publication Date Title
MX2012007041A (es) Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).
EP2623500A4 (en) MRI CONTRAST AGENT CONTAINING A GADOLINIUM COMPLEX
GB2440628B (en) Nuclear magnetic resonance measurement techinques in non-uniform fields
BRPI0809689A2 (pt) Bobina de gradiente de campo magnético, escâner por ressonância magnética, e, escâner híbrido
GB2484788B (en) Superconducting magnet having cold iron shimming capability
NL1034839A1 (nl) Magnetische-resonantieafbeeldingsapparatuur.
EP2247965A4 (en) NMR ECHOZUGKOMPRESSION
EP2408481A4 (en) CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING WITH COMPLEXES OF INOSITOL PARAMAGNETIC PHOSPHATES
EP2413794A4 (en) Support component for use in imaging by magnetic resonance and x-ray
IL216506A0 (en) Magnetic resonance imaging compatible catheter
IL209059A0 (en) Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
GB201212991D0 (en) Open-bore magnet for use in magnetic resonance imaging
WO2010094043A3 (en) Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
GB2456968B (en) Magnets for use in magnetic resonance imaging
DE602006017787D1 (de) Kontrastmittelfreie Angiographie mittels magnetischer Resonanz
GB0910138D0 (en) Combination of MIP and anatomical information
GB0700999D0 (en) Magnetic resonance imaging
WO2012151577A3 (en) Techniques to increase r1 in nanoparticle contrast agents for mri
WO2007082048A3 (en) Ex vivo hyperpolarization of imaging agents
GB2439857B (en) Shielded, asymmetric magnets for use in magnetic resonance imaging
MY148553A (en) Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use
GB0808090D0 (en) Use of magnetic proteins in medicine
WO2010124134A9 (en) In vivo1h magnetic resonance spectroscopy for the diagnosis of testicular function and disease
GB2471607B (en) Nuclear magnetic resonance measurement techniques in non-uniform fields
GB2462416B (en) Pre-polarising MRI magnet with improved openess

Legal Events

Date Code Title Description
FA Abandonment or withdrawal